NIH-funded research U01 cooperative agreement

Stanford Chronic Pancreatitis Clinical Center

Official title: The Stanford Clinical Center for the Chronic Pancreatitis Research Consortium (CPCRC)

Funded at Stanford University · NIH-11218842 · Data updated 2026-11-12

This project follows adults and children with recurrent acute or chronic pancreatitis to collect medical information and biological samples to find immune-related markers tied to symptoms and outcomes.

More Pancreatitis research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startSeptember 28, 2015
Project endJune 30, 2030
Funding year2025
Award (this year)$520,690
NIH project number2U01DK108300-11
Project IDNIH-11218842 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults and children with a history of recurrent acute pancreatitis or diagnosed chronic pancreatitis who can attend clinic visits and provide biological samples and medical information.

Less likely to help

People without pancreatitis, those unable to provide samples or attend follow-up visits, or those seeking immediate treatment benefit rather than contributing to long-term research are unlikely to receive direct benefit.

What this research studies

As someone with pancreatitis, joining means sharing health information and giving blood or other small samples over time so doctors can study how the immune system affects flare-ups and long-term problems. The Stanford center enrolls adults in the PROCEED cohort and children in the INSPPIRE2 pediatric cohort and contributes samples to the multi-site consortium. Researchers will use clinical data, imaging, and prospectively collected specimens to validate immune signaling markers they previously identified and link those markers to diagnosis, progression, and complications. A team of pancreatitis clinicians, radiologists, endocrinologists, and immunologists will coordinate collection, follow-up, and laboratory studies to improve future care.

Why it matters

Potential benefit: If successful, this work could lead to better tests to detect or predict chronic pancreatitis changes earlier and help guide more personalized care.

How similar studies have gone: Prior work within the consortium has shown promising immune-signaling markers using PROCEED samples, but wider validation and linkage to clinical outcomes remain needed.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Park, Walter Gwang-Up — Stanford University
  • Study coordinator: Park, Walter Gwang-Up

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.